Nobivac® NXT Canine Flu H3N2

• Low-volume dog influenza vaccine
• Preservative, adjuvant and thimerosal free
• Triggers a robust response without the use of an adjuvant or live organisms
• Targeted and efficient canine flu vaccine
• USDA approved. Safety and efficacy without compromise

The Nobivac^® NXT Canine Flu H3N2 is a non-adjuvanted, freeze-dried injectable canine influenza virus H3N2 vaccine, utilizing RNA particle technology. The first and only RNA-Particle Technology Vaccine for canine influenza. This dog flu vaccine stimulates expression of the desired antigen to induce a protective immune response against canine influenza virus H3N2.

This dog flu shot comes as a smaller dose- a low-volume 0.5-mL dose for a more gentle vaccine experience. No extraneous material NXT-level protection in a preservative-free, adjuvant-free, thimerosal-free formulation. Delivers the desired viral sequence to dendritic cells for an enhanced, precise immune response. Safety and efficacy without compromise. Self-amplification triggers a robust antibody and cellular immune response without the use of an adjuvant or live organisms.

Canine influenza virus (CIV) causes a respiratory infection in dogs that is also known as dog flu. The infection is very contagious to other dogs. Laboratory surveillance indicates the H3N2 strain of CIV as the critical strain of concern. This dog influenza vaccine is recommended for dogs that come from shelters, rescue centers, breeding kennels, or pet stores. In addition dogs that are boarded at a kennel or doggie daycare or are visiting groomers, dog parks, or engaging with other dogs. Ideal for dogs that participate in events/competitions, dogs that travel and dogs of veterinary staff that may be exposed through contaminated fomites. USDA approved dog vaccine.